NPCE NeuroPace, Inc.
Healthcare$16.77+0.00%OpenMarket Cap: $571.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
39.47
P/S
5.80
EV/EBITDA
-42.51
DCF Value
$-32.25
FCF Yield
-1.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
78.3%
Operating Margin
-16.8%
Net Margin
-21.7%
ROE
-120.7%
ROA
-21.8%
ROIC
-19.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $22.1M | 81.8% | $-5.6M | $-6.7M | $— | — |
| Q4 null | $26.6M | 77.4% | $-1.8M | $-2.7M | $— | — |
| FY null | $100.0M | 77.2% | $-16.3M | $-21.5M | $— | — |
| Q3 null | $27.4M | 77.4% | $-2.6M | $-3.5M | $— | — |
| Q2 null | $23.5M | 77.1% | $-6.8M | $-8.7M | $— | — |
| Q1 null | $22.5M | 77.0% | $-5.1M | $-6.6M | $— | — |
| Q4 null | $21.5M | 75.4% | $-3.7M | $-5.3M | $— | — |
| FY null | $79.9M | 73.9% | $-21.7M | $-27.1M | $— | — |
| Q3 null | $21.1M | 73.2% | $-4.2M | $-5.5M | $— | — |
| Q2 null | $19.3M | 73.4% | $-6.2M | $-7.5M | $— | — |
| Q1 null | $18.1M | 73.6% | $-7.5M | $-8.9M | $— | — |
| Q4 2023 | $18.0M | 75.2% | $-5.1M | $-6.2M | $-0.24 | — |